A cocktail of rapamycin, acarbose, and phenylbutyrate prevents age-related cognitive decline in mice by targeting multiple aging pathways
Open accessThe DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Abstract
Aging is a primary risk factor for cognitive impairment and exacerbates multiple biological processes in the brain, including but not limited to nutrient sensing, insulin signaling, and histone deacetylation activity. Therefore, a pharmaceutical intervention of aging that targets distinct but overlapping pathways provides a basis for testing combinations of drugs as a cocktail. Our previous study showed that middle-aged mice treated with a cocktail of rapamycin, acarbose, and phenylbutyrate for 3 months had increased resilience to age-related cognitive decline. This finding provided the rationale to investigate the transcriptomic and molecular changes within the brains of mice that received this cocktail treatment or control treatment. Transcriptomic profiles were generated through ribonucleic acid (RNA) sequencing, and pathway analysis was performed by gene set enrichment analysis to evaluate the overall RNA message effect of the drug cocktail. Molecular endpoints representing aging pathways were measured using immunohistochemistry to further validate the attenuation of brain aging in the hippocampus of mice that received the cocktail treatment, each individual drug or control. Results showed that biological processes that enhance aging were suppressed, with an increased trend of autophagy in the brains of mice given the drug cocktail. The molecular endpoint assessments indicated that treatment with the drug cocktail was overall more effective than any of the individual drugs for relieving cognitive impairment by targeting multiple aging pathways.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“With effects on these factors, the drug cocktail effectively inhibits biological processes that contribute to ageing, such as DNA damage, inflammation, and cell senescence, while simultaneously promoting a significant increase in autophagy.409”
From Antiageing strategy for neurodegenerative diseases: from mechanisms to clinical advances (2025) · cites this paper as [409]
In the citing paper
“Through RNA sequencing, the drug cocktail subsequently downregulates the transcriptomic profiles of three major ageing pathways, namely, the mTOR, IIS and histone deacetylase binding pathways.”
From Antiageing strategy for neurodegenerative diseases: from mechanisms to clinical advances (2025) · cites this paper as [409]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Rapamycin suppresses the PI3K/AKT/mTOR signaling pathway by targeting SIRT1 in esophageal cancer
Liu, T., Liang, X., Sun, Y., & Yang, S. (2021) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2021.10624 · Cited by 9 · cited 1×
“Rap was found to suppress the down-stream complexes of mTOR1 signaling including NF-κB [43], STAT3 [44], and Akt signaling [45], hence reducing cellular senescence [1, 46].”
BackgroundRetractedModerated estimation of fold change and dispersion for RNA-seq data with DESeq2
Love, M. I., Huber, W., & Anders, S. (2014) · Genome Biology · doi:10.1186/s13059-014-0550-8 · Cited by 95,106
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
López-Otín, C., Blasco, M. A., Partridge, L., Serrano, M., & Kroemer, G. (2013) · Cell · doi:10.1016/j.cell.2013.05.039 · Cited by 14,982
The Molecular Signatures Database Hallmark Gene Set Collection
Liberzon, A., Birger, C., Thorvaldsdóttir, H., Ghandi, M., Mesirov, J. P., & Tamayo, P. (2015) · Cell Systems · doi:10.1016/j.cels.2015.12.004 · Cited by 13,807 · cited 1×
“0 [20, 22].”
Mootha, V. K., Lindgren, C. M., Eriksson, K.-F., Subramanian, A., Sihag, S., Lehar, J., Puigserver, P., Carlsson, E., Ridderstråle, M., Laurila, E., et al. (2003) · Nature Genetics · doi:10.1038/ng1180 · Cited by 10,197 · cited 2×
“GSEA (RRID:SCR_003199) is a useful tool to interpret high throughput expression studies and identify insights into biological pathways underlying a given phenotype [20, 21].”
MethodInfluentialHallmarks of aging: An expanding universe
López-Otín, C., Blasco, M. A., Partridge, L., Serrano, M., & Kroemer, G. (2023) · Cell · doi:10.1016/j.cell.2022.11.001 · Cited by 6,549 · cited 5×
“The groups of pathways selected for GSEA analysis were predefined by previous studies [1] as major pathways of mammalian aging.”
BackgroundMethodInfluentialRapamycin fed late in life extends lifespan in genetically heterogeneous mice
Harrison, D. E., Strong, R., Sharp, Z. D., Nelson, J. F., Astle, C. M., Flurkey, K., Nadon, N. L., Wilkinson, J. E., Frenkel, K., Carter, C. S., et al. (2009) · Nature · doi:10.1038/nature08221 · Cited by 3,766
Extending Healthy Life Span—From Yeast to Humans
Fontana, L., Partridge, L., & Longo, V. D. (2010) · Science · doi:10.1126/science.1172539 · Cited by 3,023 · cited 2×
“Insulin signaling is one of the most conserved aging-controlling pathways in evolution [24–26].”
BackgroundKenyon, C. J. (2010) · Nature · doi:10.1038/nature08980 · Cited by 2,739 · cited 1×
“Insulin signaling is one of the most conserved aging-controlling pathways in evolution [24–26].”
BackgroundMTOR: a pharmacologic target for autophagy regulation
Kim, Y. C., & Guan, K.-L. (2015) · Journal of Clinical Investigation · doi:10.1172/jci73939 · Cited by 2,126 · cited 1×
“Rap can restore the autophagic flux and enhance autophagy by restoring mitochondrial and lysosomal functions [48].”
BackgroundmTOR is a key modulator of ageing and age-related disease
Johnson, S. C., Rabinovitch, P. S., & Kaeberlein, M. (2013) · Nature · doi:10.1038/nature11861 · Cited by 1,676 · cited 1×
“Rap blocks mTOR1, a protein shown to integrate signals from growth factors and nutrients to control protein synthesis [10].”
BackgroundRole of AMPK-mTOR-Ulk1/2 in the regulation of autophagy: cross talk, shortcuts, and feedbacks
Alers, S., Löffler, A. S., Wesselborg, S., & Stork, B. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.06159-11 · Cited by 1,483 · cited 1×
“ATG5, a common biomarker for measuring autophagy, binds with beclin and promotes macroau-tophagy induction [38].”
BackgroundPetersen, R. C. (2011) · New England Journal of Medicine · doi:10.1056/nejmcp0910237 · Cited by 1,289 · cited 1×
“This deterioration can lead to early stages of neurodegenerative conditions such as Alzheimer’s disease and other dementias, affecting millions of older people [39].”
Background-H2AX in recognition and signaling of DNA double-strand breaks in the context of chromatin
Kinner, A., Wu, W., Staudt, C., & Iliakis, G. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkn550 · Cited by 1,256
ROS, Cell Senescence, and Novel Molecular Mechanisms in Aging and Age‐Related Diseases
Davalli, P., Mitic, T., Caporali, A., Lauriola, A., & D’Arca, D. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/3565127 · Cited by 1,059
The Critical Role of Metabolic Pathways in Aging
Barzilai, N., Huffman, D. M., Muzumdar, R. H., & Bartke, A. (2012) · Diabetes · doi:10.2337/db11-1300 · Cited by 803
Human HDAC1 and HDAC2 function in the DNA-damage response to promote DNA nonhomologous end-joining
Miller, K. M., Tjeertes, J. V., Coates, J., Legube, G., Polo, S. E., Britton, S., & Jackson, S. P. (2010) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1899 · Cited by 629 · cited 1×
“HDAC2 is a class I histone deacetylation protein that participates in the DNA damage response as it is rapidly recruited to DNA damage sites to promote hypo-acetylation [34]. γH2AX refers to the X isoform of the histone H2A which resides closely with DNA as a part of the nucleosome.”
BackgroundMiller, R. A., Harrison, D. E., Astle, C. M., Fernandez, E., Flurkey, K., Han, M., Javors, M. A., Li, X., Nadon, N. L., Nelson, J. F., et al. (2014) · Aging Cell · doi:10.1111/acel.12194 · Cited by 621 · cited 2×
“Selection of these specific drugs for a multiplex approach was based on their well-established roles in promoting health span and prolonging lifespan in mice [4, 11, 15].”
BackgroundHarrison, D. E., Strong, R., Allison, D. B., Ames, B. N., Astle, C. M., Atamna, H., Fernandez, E., Flurkey, K., Javors, M. A., Nadon, N. L., et al. (2014) · Aging Cell · doi:10.1111/acel.12170 · Cited by 445
Immunobiology: The immune system in health and disease
Norman, P. S. (1995) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(95)70025-0 · Cited by 428 · cited 2×
“Increased activation of TNF-alpha induces both acute and chronic neuro-inflammation [31].”
BackgroundCellular senescence: Molecular mechanisms and pathogenicity
Wei, W., & Ji, S. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.26956 · Cited by 210 · cited 1×
“As senescence accumulates with increasing age, an elevated expression of both systemic and local senescence-associated secretory phenotype (SASP) is observed in neuronal cells [32].”
BackgroundIL-6-STAT3 signaling and premature senescence
Kojima, H., Inoue, T., Kunimoto, H., & Nakajima, K. (2013) · JAK-STAT · doi:10.4161/jkst.25763 · Cited by 170 · cited 1×
“Rap was found to suppress the down-stream complexes of mTOR1 signaling including NF-κB [43], STAT3 [44], and Akt signaling [45], hence reducing cellular senescence [1, 46].”
BackgroundLesniewski, L. A., Seals, D. R., Walker, A. E., Henson, G. D., Blimline, M. W., Trott, D. W., Bosshardt, G. C., LaRocca, T. J., Lawson, B. R., Zigler, M. C., et al. (2017) · Aging Cell · doi:10.1111/acel.12524 · Cited by 166
Lin, A.-L., Jahrling, J. B., Zhang, W., DeRosa, N., Bakshi, V., Romero, P., Galvan, V., & Richardson, A. (2017) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x15621575 · Cited by 155
The immunobiology of mTOR in autoimmunity
Suto, T., & Karonitsch, T. (2020) · Journal of Autoimmunity · doi:10.1016/j.jaut.2019.102373 · Cited by 149 · cited 1×
“Rap as an anti-proliferative mTOR1 inhibitor was proven to prevent endothelial cell overgrowth and is considered a potential reagent for suppressing the primary immune response [41].”
BackgroundAcarbose improves health and lifespan in aging HET3 mice
Harrison, D. E., Strong, R., Alavez, S., Astle, C. M., DiGiovanni, J., Fernandez, E., Flurkey, K., Garratt, M., Gelfond, J. A. L., Javors, M. A., et al. (2019) · Aging Cell · doi:10.1111/acel.12898 · Cited by 141 · cited 2×
“Selection of these specific drugs for a multiplex approach was based on their well-established roles in promoting health span and prolonging lifespan in mice [4, 11, 15].”
BackgroundThe mTOR–S6K pathway links growth signalling to DNA damage response by targeting RNF168
Xie, X., Hu, H., Tong, X., Li, L., Liu, X., Chen, M., Yuan, H., Xie, X., Li, Q., Zhang, Y., et al. (2018) · Nature Cell Biology · doi:10.1038/s41556-017-0033-8 · Cited by 133 · cited 2×
“The DNA repair pathway from the GO database includes both up-and down-stream genes involved with DNA repair that makes this an ideal illustration for addressing the level of DNA damage [30].”
BackgroundIncreased acetyl and total histone levels in post-mortem Alzheimer's disease brain
Narayan, P. J., Lill, C., Faull, R., Curtis, M. A., & Dragunow, M. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.11.023 · Cited by 132 · cited 1×
“Downregulated histone deacetylation alters accessibility of chromatin and allows DNA-binding proteins to interact with exposed sites to activate gene transcription and downstream cellular function [28, 29].”
BackgroundHDAC inhibitors: A new promising drug class in anti-aging research
Pasyukova, E. G., & Vaiserman, A. M. (2017) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2017.08.008 · Cited by 99 · cited 1×
“…that increases in histone acetylation globally elevate transcription, which can be beneficial at old age as it contributes to the reversion of age-dependent decline in stress response, deoxyribonucleic acid (DNA) repair, and other genes involved in the maintenance of homeostasis [15, 16].”
BackgroundAbbatecola, A. M., Lattanzio, F., Molinari, A. M., Cioffi, M., Mansi, L., Rambaldi, P., DiCioccio, L., Cacciapuoti, F., Canonico, R., & Paolisso, G. (2010) · Diabetes Care · doi:10.2337/dc09-2030 · Cited by 93 · cited 1×
“Current evidence suggests that interventions that constitutively decreased insulin signaling may prevent or reverse the adverse effects associated with aging [27].”
BackgroundRapamycin‐mediated mouse lifespan extension: Late‐life dosage regimes with sex‐specific effects
Strong, R., Miller, R. A., Bogue, M., Fernandez, E., Javors, M. A., Libert, S., Marinez, P. A., Murphy, M. P., Musi, N., Nelson, J. F., et al. (2020) · Aging Cell · doi:10.1111/acel.13269 · Cited by 92
Anti‐aging drugs reduce hypothalamic inflammation in a sex‐specific manner
Sadagurski, M., Cady, G., & Miller, R. A. (2017) · Aging Cell · doi:10.1111/acel.12590 · Cited by 82
Wiley, J. C., Meabon, J. S., Frankowski, H., Smith, E. A., Schecterson, L. C., Bothwell, M. A., & Ladiges, W. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009135 · Cited by 76 · cited 4×
“Selection of these specific drugs for a multiplex approach was based on their well-established roles in promoting health span and prolonging lifespan in mice [4, 11, 15].”
BackgroundInfluentialSelf-citationSabe, S. A., Feng, J., Sellke, F. W., & Abid, M. R. (2022) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00603.2021 · Cited by 76 · cited 1×
“Increasing evidence implicates cellular senescence in tissue is associated with dysregulated insulin regulation [47], which suggests that Acb may contribute to reducing the senescence-associated inflammatory response.”
BackgroundBrain Parenchymal and Extraparenchymal Macrophages in Development, Homeostasis, and Disease
Brioschi, S., Zhou, Y., & Colonna, M. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.1900821 · Cited by 68 · cited 1×
“IL-6 is secreted by parenchymal macrophages in the CNS and is critical for the progression of inflammatory disorders of neural tissue [37].”
BackgroundHou, H., Miao, J., Cao, R., Han, M., Sun, Y., Liu, X., & Guo, L. (2017) · Neurochemical Research · doi:10.1007/s11064-017-2296-7 · Cited by 63 · cited 1×
“Rap was found to suppress the down-stream complexes of mTOR1 signaling including NF-κB [43], STAT3 [44], and Akt signaling [45], hence reducing cellular senescence [1, 46].”
BackgroundMolecular pathology endpoints useful for aging studies
Niedernhofer, L. J., Kirkland, J. L., & Ladiges, W. (2017) · Ageing Research Reviews · doi:10.1016/j.arr.2016.09.012 · Cited by 59 · cited 2×
“P16 and P21 are endpoints for identifying senescence phenotypes in murine models [36].”
BackgroundSelf-citationHarrison, D. E., Strong, R., Reifsnyder, P., Rosenthal, N., Korstanje, R., Fernandez, E., Flurkey, K., Ginsburg, B. C., Murrell, M. D., Javors, M. A., et al. (2023) · GeroScience · doi:10.1007/s11357-023-01011-0 · Cited by 56
Dai, J., Jiang, C., Chen, H., & Chai, Y. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01292 · Cited by 54 · cited 1×
“Rap was found to suppress the down-stream complexes of mTOR1 signaling including NF-κB [43], STAT3 [44], and Akt signaling [45], hence reducing cellular senescence [1, 46].”
BackgroundEpigenetic assimilation in the aging human brain
Oh, G., Ebrahimi, S., Wang, S.-C., Cortese, R., Kaminsky, Z. A., Gottesman, I. I., Burke, J. R., Plassman, B. L., & Petronis, A. (2016) · Genome Biology · doi:10.1186/s13059-016-0946-8 · Cited by 51 · cited 1×
“Downregulated histone deacetylation alters accessibility of chromatin and allows DNA-binding proteins to interact with exposed sites to activate gene transcription and downstream cellular function [28, 29].”
BackgroundTouzot, M., Soulillou, J., & Dantal, J. (2012) · Current Opinion in Organ Transplantation · doi:10.1097/mot.0b013e32835a4be2 · Cited by 32 · cited 1×
“Rap is an antibiotic clinically approved for treating organ transplant patients and neoplastic conditions [8, 9].”
BackgroundGibbs, V. K., Brewer, R. A., Miyasaki, N., Patki, A., & Smith, D. L. (2017) · The Journals of Gerontology Series A · doi:10.1093/gerona/glx127 · Cited by 30 · cited 1×
“Specifically, Acb reversibly inhibits α-glucosidases within the intestinal brush border and promotes postprandial blood glucose regulation [14].”
BackgroundJiang, Z., Wang, J., Imai, D., Snider, T., Klug, J., Mangalindan, R., Morton, J., Zhu, L., Salmon, A. B., Wezeman, J., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-11229-1 · Cited by 21 · cited 1×
“All procedures were approved by the University of Washington IACUC as previously reported (Jiang et al., 2022).”
MethodSelf-citationPhenylbutyrate inhibits homologous recombination induced by camptothecin and methyl methanesulfonate
Kaiser, G. S., Germann, S. M., Westergaard, T., & Lisby, M. (2011) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2011.05.016 · Cited by 15
Carvajal‐Flores, F. N., Díaz, A., Flores‐Gómez, G. D., de la Cruz, F., & Flores, G. (2020) · Synapse · doi:10.1002/syn.22177 · Cited by 13 · cited 1×
“Pathways including mammalian target of rapamycin (mTOR) signaling, insulin signaling, and histone deacetylation [1] are respectively and individually targeted by rapamycin (Rap), acarbose (Acb), and phenylbutyrate (Pba), with each drug shown to have anti-aging effects in mice [2–6].”
BackgroundQuPath. A new digital imaging tool for geropathology
Lee, A., Jiang, Z., Zhu, L., & Ladiges, W. (2020) · Aging Pathobiology and Therapeutics · doi:10.31491/apt.2020.06.024 · Cited by 10 · cited 1×
“0 was used for positive stained cell identification and optical density quantification [23].”
MethodSelf-citationSirolimus: mammalian target of rapamycin inhibitor to prevent kidney rejection.
Cowan, P. A., & Heizer, K. E. (2000) · PubMed · Cited by 7
The rationale for testing drug combinations in aging intervention studies
Sharma, K., Wang, J., Jiang, Z., Klug, J., Darvas, M., M. Imai, D., Snider, T., Niedernhofer, L., & Ladiges, W. (2019) · Aging Pathobiology and Therapeutics · doi:10.31491/apt.2019.12.001 · Cited by 4 · cited 3×
“( 1234567890) slowing aging in the brain due to targeting multiple aging pathways [7].”
BackgroundInfluentialSelf-citation
Cited by
Antiageing strategy for neurodegenerative diseases: from mechanisms to clinical advances
Jiang, Q., Liu, J., Huang, S., Wang, X.-Y., Chen, X., Liu, G.-H., Ye, K., Song, W., Masters, C. L., Wang, J., et al. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02145-7 · Cited by 165
“409 Antiageing drugs have favourable effects on neurodegenerative diseases.”
Zhang, G., Wei, H., Zhao, A., Xu, Y., Zhang, X., Gan, J., Guo, M., Wang, J., Zhang, F., Jiang, Y., et al. (2025) · Journal of Neuroinflammation · doi:10.1186/s12974-025-03363-0 · Cited by 88
“…Rapamycin Autophagy inducer Blocks mtDNA release and various PRRs activation [41, 193, 342, 343] Spinal cord injury [344], cognitive dysfunction [417], depression [418], Sturge-Weber syndrome [345] Hydroxychloroquine Activator of mitophagy Diminish mtDNA accumulation in TLR9 endosomes and…”
Aronoff, J. E., & Trumble, B. C. (2025) · Evolution Medicine and Public Health · doi:10.1093/emph/eoaf010 · Cited by 17
“The greater efficacy of therapeutics through targeting multiple pathways has been highlighted in neurodegeneration as well, further suggesting that degeneracy should be an important consideration for therapeutics [126, 127].”
Age-Related Alterations of Cerebral Autoregulation
Ungvari, A., Kállai, A., Stankovics, L., Lendvai-Emmert, D., Gulej, R., Pal, E., Patai, R., Csik, B., Fekete, M., Lipecz, Á., et al. (2025) · Life · doi:10.3390/life15111669 · Cited by 14
“Various anti-aging treat-ment regimens [166], including antioxidants [167], mTOR inhibitors [168], and senolyt-ics [158,169] that selectively eliminate senescent cells are under investigation for their potential to rejuvenate vascular function, including cerebral autoregulatory capacity.”
Zhong, L., Yang, J., Syed, J. N., Zhang, Y., Tian, Y., & Fu, X. (2025) · Aging and Disease · doi:10.14336/ad.2024.1477 · Cited by 18
“The combined therapy of rapamycin, acarbose, and phenylbutyrate for three months demonstrated enhanced recovery of aging-related cognitive decline in middle-aged mice [76].”
Metadata
- Authors
- Jiang, Z., He, Q., Wezeman, J., Darvas, M., & Ladiges, W.
- Affiliations
- University of Washington (US)
- Corresponding author
- Ladiges, Warren
- Venue
- GeroScience
- Published
- 2024-05-16
- Volume
- 46
- Issue
- 5
- Pages
- 4855-4868
- ISSN
- 2152-4041 (ISSN-L)
- 2509-2723
- PMC
- PMC11336069
- OpenAlex
- W4396977969
- Cited by
- 10
- References
- 48
- Citations by year
- 2026: 1 · 2025: 8 · 2024: 1
- FWCI
- 1.21
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- GeroScience (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- National Institute on Aging (R01 AG057381)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Antioxidants, Aging, Portulaca oleracea
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
- Keywords
- drug mixtures, rapamycin, acarbose, 4-phenylbutyric acid, age-related cognitive decline, brain aging, hippocampus, autophagy, insulin signaling, nutrient sensing, histone deacetylation, gene expression profiling, combination therapy
- MeSH terms
- Aging, Animals, Autophagy, Disease Models, Animal, Drug Therapy, Combination, Hippocampus, Male, Mice, Inbred C57BL, Phenylbutyrates, Sirolimus, Acarbose, Mice, Transcriptome, Cognitive Dysfunction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.